[{"Assets_0_Q3_USD":2088294000.0,"CommonStockSharesOutstanding_0_Q3_shares":175786000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-203458000.0,"NetIncomeLoss_1_Q3_USD":-98808000.0,"NetIncomeLoss_3_Q3_USD":-327229000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":175402000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":174609000.0,"StockholdersEquity_0_Q3_USD":1488711000.0,"EarningsPerShareBasic_1_Q3_USD":-0.56,"EarningsPerShareBasic_3_Q3_USD":-1.87,"Ticker":"NKTR","CIK":"906709","name":"NEKTAR THERAPEUTICS","OfficialName":"Nektar Therapeutics  Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"862449342.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]